From theheart.org on Medscape

News from the

American Heart Association (AHA) 2015 Scientific Sessions

November 07 - 11, 2015; Orlando, Florida

Visit Medscape at Booth #1015

The Cardiology Show

The Cardiology Show From AHA 2015 With Dr Valentin Fuster The SPRINT hypertension trial tops a show that also covers in-ambulance troponin testing, repair vs replace for ischemic mitral regurgitation, peer counseling to reduce CV risk factors, and four runners-up trials.

Meeting Highlights at a Glance

Top News From AHA 2015: Slideshow Highlights include practice-changing full results of the SPRINT hypertension trial, plus mitral-valve replacement beats repair for 2-year durability in ischemic mitral regurgitation.

Conference News

AHA Triple Antithrombotics for PCI Up Bleed Risk in Oldest With AF
Heartwire from Medscape, November 27, 2015
AHA Cardiac Sonographers Extra Prone to Back, Neck, Wrist Pain
Heartwire from Medscape, November 27, 2015
AHA hs-Troponins Rival CCTA For Spotting Signficant CAD: BEACON
Heartwire from Medscape, November 25, 2015
AHA Beta-3 Agonist Mirabegron May Help in Severe HF, BEAT HF Hints
Heartwire from Medscape, November 24, 2015
AHA ANNEXA-R: Novel Agent Sustains Anticoagulation Reversal
Heartwire from Medscape, November 20, 2015
AHA No Ranolazine Benefit Against Angina Seen in Small-Vessel CAD
Heartwire from Medscape, November 20, 2015
AHA Myosin-Activating Heart-Failure Med Advances in Small Trial
Heartwire from Medscape, November 20, 2015
AHA MI-GENES: Disclosing Genetic Risk for CHD May Lower LDL-C Levels
Heartwire from Medscape, November 19, 2015
AHA SPRINT and BP Management: 'Groundbreaking' but Questions Remain
Heartwire from Medscape, November 18, 2015
AHA Functional Gains With LV Gel Scaffold Durable at 1 Year
Heartwire from Medscape, November 18, 2015
AHA Dyspnea, Minor Bleeds Led Causes for Stopping Ticagrelor in Trial
Heartwire from Medscape, November 17, 2015
AHA Empagliflozin's CV Gains Explored in Diabetics With, Without HF
Heartwire from Medscape, November 16, 2015
AHA U-Shaped HDL-C Mortality Curve Seen in Canada-Based Analysis
Heartwire from Medscape, November 16, 2015
AHA Micra Leadless Pacemaker Upholds Promise in Prospective Study
Heartwire from Medscape, November 16, 2015
AHA Focus More on % LDL Reductions: New JUPITER Data
Heartwire from Medscape, November 13, 2015
AHA CABG Preferable to PCI for Multivessel Disease in Diabetics
Heartwire from Medscape, November 13, 2015
AHA Candesartan May Cut Cardiotoxicity in Breast Cancer Patients
Heartwire from Medscape, November 12, 2015
AHA Heart-Attack Patients Should Be Tested, Treated for Diabetes
Medscape Medical News, November 12, 2015
AHA App Plus Coaching Can Change Four Heart-Health Habits at Once
Heartwire from Medscape, November 12, 2015

AHA Extend SPRINT Results to Diabetics: New ACCORD Data
Heartwire from Medscape, November 11, 2015
AHA Nitric Oxide Reduces Kidney Injury in Heart-Valve Surgery
Heartwire from Medscape, November 11, 2015
AHA IVUS-Guided PCI With Xience Stent Reduces Revascularizations
Heartwire from Medscape, November 11, 2015
AHA CANOA: Clopidogrel Reduces Migraine After ASD Closure
Heartwire from Medscape, November 10, 2015
AHA Ranolazine May Improve Post-PCI Angina Frequency in Diabetics
Heartwire from Medscape, November 10, 2015
AHA Liraglutide No Match for Heart Failure in Early Round of FIGHT
Heartwire from Medscape, November 10, 2015
AHA PROACT-4: Mixed Results With Point-of-Care Troponin Testing
Heartwire from Medscape, November 10, 2015
AHA Inappropriate PCI Is on the Decline, New US Data Show
Heartwire from Medscape, November 10, 2015
AHA Rethink Continuous-Compression CPR by EMS: Randomized Trial
Heartwire from Medscape, November 10, 2015
AHA Peer-Based Support Program Promotes Heart-Healthy Behaviors
Heartwire from Medscape, November 10, 2015
AHA SPRINT: Push BP Target Lower in High-CV-Risk HTN Patients
Heartwire from Medscape, November 9, 2015
AHA Prosthesis Beats Repair for 2-Year Durability in Ischemic MR
Heartwire from Medscape, November 9, 2015
AHA Vericiguat Misses End Point of Lowering NT-proBNP in Chronic HF
Heartwire from Medscape, November 9, 2015
AHA Varenicline Started in ACS Hospitalization Helps Smokers Quit
Heartwire from Medscape, November 9, 2015
AHA Pay, Subspecialties Differ for Female vs Male Cardiologists
Heartwire from Medscape, November 8, 2015
AHA Caffeine-Loaded Energy Drink Increases Blood Pressure
Heartwire from Medscape, November 8, 2015
AHA BEAT-HF: Remote Telemonitoring Fails to Prevent HF Rehospitalizations
Heartwire from Medscape, November 8, 2015
AHA NEAT-HFpEF: Activity Levels Fall on Nitrates in Preserved-EF HF
Heartwire from Medscape, November 8, 2015
AHA Orlando Adds Cardiology Theme Park November 7: AHA 2015
Heartwire from Medscape, November 3, 2015

Perspectives from AHA

AUGMENT-HF: A Novel Approach to Cardiac Remodeling
Ileana L. Piña, MD, MPH
What Influences Your Therapeutic Choices?
Michelle L. O'Donoghue, MD, MPH
The Role of Vascular Medicine in Cardiology
Samuel Z. Goldhaber, MD
Vascular Disease Wake-up Call From AHA President Mark Creager
Ileana L. Piña, MD, MPH
EMPA-REG, PCSK9s, and the Future of Clinical Trials
Michelle L. O'Donoghue, MD, MPH; Marc S. Sabatine, MD, MPH
Preventing Cardiac Dysfunction During Breast Cancer Therapy
John M. Mandrola, MD
Reconciling SPRINT and ACCORD: Dr Marc Sabatine Interviewed
Michelle L. O'Donoghue, MD, MPH; Marc S. Sabatine, MD, MPH
Hypertension Affects VTE Too
Samuel Z. Goldhaber, MD
Hypertension Management After SPRINT: Fast Forward or Pause?
Clyde W. Yancy, MD, MSc; Vera A. Bittner, MD, MSPH; Anne B. Curtis, MD; Patrick O'Gara, MD
SPRINT Trial: Dr Paul Whelton Interviewed
John M. Mandrola, MD

Live Blog

News and Views from AHA 2015 Coverage of key advances and expert reactions as they happened at the meeting.

BLOGGERS FROM THE FLOOR

A Big Blind Spot in Anticoagulation Guidelines Dr John Mandrola recounts a presentation in which a wide variety of stroke risk was detected in various cohorts of patients with AF not on anticoagulation.
Fast and Slow Thinking on the SPRINT Trial Dr John Mandrola reflects on the SPRINT trial and the role of lifestyle, shared decision making, and patient selection, with comments from some outside experts.
ARREST-AF Substrate Study: Strong 'Medicine' vs Medication Dr John Mandrola reports on the results of this study, in which risk-factor management improved the health of people and their atria.
AHA 2015 Scientific Sessions Previewed by John Mandrola Dr John Mandrola peruses the program for the upcoming American Heart Association Scientific Sessions in Orlando and outlines the studies he'll be looking out for.
Ticagrelor and Science: Is the Dyspnea Really Worth It? Dr Melissa Walton-Shirley reports on the presentation about the long-term tolerability of ticagrelor in PEGASUS vs the results of her experience with the drug.
New ACS Cocktail: ASA, Antiplatelets, Beta-blockers, and Now Varenicline? Dr Melissa Walton-Shirley reports on the impressive results of the EVITA varenicline trial in the highest-risk population possible: MI patients in the hospital.
Succinct Thoughts on NEAT-HFpEF: True, True, and Unrelated? Dr Melissa Walton-Shirley suspects that the NEAT-HFpEF findings may be a case of ''true, true and unrelated" because correlation does not necessarily reflect causation.
The 'Other' Women: Clinicians Be Bold, and Engage in Heart Speak Dr Melissa Walton-Shirley reports on a presentation on information from the Women's Heart Alliance and reflects on the wife of a long-time patient.

Previous Coverage